Use the Back button in your browser to see the other results of your search or to select another record.
Cost-utility and cost-effectiveness of physical exercise during adjuvant chemotherapy |
van Waart H, van Dongen JM, van Harten WH, Stuiver MM, Huijsmans R, Hellendoorn-van Vreeswijk JAJH, Sonke GS, Aaronson NK |
European Journal of Health Economics 2018 Jul;19(6):893-904 |
clinical trial |
6/10 [Eligibility criteria: No; Random allocation: Yes; Concealed allocation: No; Baseline comparability: Yes; Blind subjects: No; Blind therapists: No; Blind assessors: No; Adequate follow-up: Yes; Intention-to-treat analysis: Yes; Between-group comparisons: Yes; Point estimates and variability: Yes. Note: Eligibility criteria item does not contribute to total score] *This score has been confirmed* |
Copyright release for this abstract has not been granted.
|